Industry Intelligence
Healthcare innovation from BioLargo and Clyra Medical focuses on FDA-cleared wound irrigation, infection control, and advanced care solutions for government and clinical markets.
BioLargo says Clyra Medical is adding Spartan Medical as a distribution channel for ViaCLYR wound irrigation solution across government healthcare facilities worldwide.
AI/ML Innovations has appointed Dr. Mehmet Kosoglu as Head of Regulatory at its wholly owned subsidiary NeuralCloud Solutions, which is developing AI-powered cardiac technologies.
ZEO ScientifiX has announced the multidisciplinary faculty and guest speaker lineup for the inaugural ZEO Xperience, scheduled for October 23-25, 2026, in Fort Lauderdale, Florida.
CASI Pharmaceuticals, Inc. has reported its financial and business results for the first half of 2026, including notable progress in clinical trials while grappling with operational financial challenges.
Microbix Biosystems Inc. reported a 17% revenue increase in Q3 fiscal 2026, although year-to-date revenues decreased by 21%. The company is actively pursuing growth after client setbacks.
Revive Therapeutics Ltd. reports significant findings from a study on bucillamine's effectiveness against nerve-agent exposure, showing no associated pulmonary hemorrhage compared to N-acetylcysteine.
CV Sciences, Inc. has introduced PlusHLTH.com, expanding its product offerings beyond cannabinoids to focus on healthy aging and overall wellness.